Stilla Technologies Stilla Technologies Adds dPCR Oncology Menu, End Users as Part of Clinical Pivot Premium The firm is seeing the fruit of a two-year investment in transitioning from a research lab to a clinical focus. Breaking News BioNexus Gene Lab, Shenzhen Rongguang Team up on Cancer Screening, Precision Medicine Programs Population Testing for BRCA1/2 Appears Cost-Effective in Younger Canadian Women Octernal Stopping Clinical Testing, Reducing Workforce After Safety, Efficacy Issues in Two Trials NKGen Biotech Doses First Patient in Phase II Portion of Alzheimer's Cell Therapy Trial Massive Bio, Foundation Medicine Partner to Improve Oncology Clinical Trial Enrollment In Brief This Week: Sophia Genetics, Cartesian, NS Pharma, Allarity, Cabrini Health
